{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:39Z","timestamp":1791928899412,"version":"4.3.4"},"reference-count":31,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"15","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,12,5]]},"DOI":"10.1167\/iovs.66.15.23","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:30:35Z","timestamp":1764945035000},"page":"23","source":"Crossref","is-referenced-by-count":2,"title":["Conformational Dynamics of PKM2 Regulate Hypoxia-Induced Pathological Retinal Angiogenesis"],"prefix":"10.1167","volume":"66","author":[{"given":"Peiwen","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Vision Science, Eye and Ear, Nose and Throat Hospital of Fudan University, Shanghai, People's Republic of China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, People's Republic of China"},{"name":"NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, Eye and Ear, Nose and Throat Hospital of Fudan University, Shanghai, People's Republic of China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, People's Republic of China"},{"name":"NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, Eye and Ear, Nose and Throat Hospital of Fudan University, Shanghai, People's Republic of China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, People's Republic of China"},{"name":"NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, Eye and Ear, Nose and Throat Hospital of Fudan University, Shanghai, People's Republic of China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, People's Republic of China"},{"name":"NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, Eye and Ear, Nose and Throat Hospital of Fudan University, Shanghai, People's Republic of China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, People's Republic of China"},{"name":"NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"4","key":"bib1","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00431-024-05450-5","article-title":"Visual impairment burden in retinopathy of prematurity: trends, inequalities, and improvement gaps","volume":"183","author":"Chen","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"10","key":"bib2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/iovs.61.10.14","article-title":"Incidence, long-term visual outcomes, and mortality in retinopathy of prematurity in Korea: a nationwide population-based study","volume":"61","author":"Na","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nsmb.2219","article-title":"Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins","volume":"19","author":"Chen","year":"2012","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"bib4","doi-asserted-by":"publisher","first-page":"103949","DOI":"10.1016\/j.drudis.2024.103949","article-title":"Rare diseases and pyruvate kinase M2: a promising therapeutic connection","volume":"29","author":"Kapoor","year":"2024","journal-title":"Drug Discov Today"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: Function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"112675","DOI":"10.1016\/j.intimp.2024.112675","article-title":"The potential roles of PKM2 in cerebrovascular diseases","volume":"139","author":"Ma","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"bib7","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s44318-024-00110-8","article-title":"PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer","volume":"43","author":"Wang","year":"2024","journal-title":"EMBO J"},{"issue":"2","key":"bib8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12265-022-10321-1","article-title":"Role of pyruvate kinase M2 (PKM2) in cardiovascular diseases","volume":"16","author":"Rihan","year":"2023","journal-title":"J Cardiovasc Transl Res"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"bib10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"issue":"5","key":"bib11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2011.05.009","article-title":"PK-M2 makes cells sweeter on HIF1","volume":"145","author":"Tennant","year":"2011","journal-title":"Cell"},{"issue":"10","key":"bib12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis","volume":"8","author":"Anastasiou","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1a activity and IL-1\u00df induction and is a critical determinant of the Warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab"},{"issue":"40","key":"bib14","doi-asserted-by":"publisher","first-page":"e2123231119","DOI":"10.1073\/pnas.2123231119","article-title":"Dual roles of \u00df-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer","volume":"119","author":"Yu","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"bib15","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"issue":"3","key":"bib16","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1096\/fj.201801086RR","article-title":"Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy","volume":"33","author":"Chen","year":"2019","journal-title":"Faseb j"},{"issue":"7","key":"bib17","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division. Evidence that \u2018physiological hypoxia\u2019 is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib18","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1167\/iovs.08-2584","article-title":"Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture","volume":"49","author":"Smith","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"bib19","doi-asserted-by":"publisher","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"bib20","doi-asserted-by":"publisher","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"bib21","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"bib22","first-page":"615","article-title":"Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity","volume":"119","author":"Kaiser","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"bib24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaapos.2004.10.007","article-title":"Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity","volume":"9","author":"Trigler","year":"2005","journal-title":"J AAPOS"},{"issue":"4","key":"bib25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10456-015-9475-4","article-title":"KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma","volume":"18","author":"Ma","year":"2015","journal-title":"Angiogenesis"},{"issue":"5","key":"bib26","doi-asserted-by":"publisher","first-page":"e2417515122","DOI":"10.1073\/pnas.2417515122","article-title":"Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis","volume":"122","author":"Jiang","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"bib27","doi-asserted-by":"publisher","first-page":"e70348","DOI":"10.1096\/fj.202401989RR","article-title":"Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1alpha","volume":"39","author":"Hartman","year":"2025","journal-title":"FASEB J"},{"issue":"2","key":"bib28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14791\/btrt.2013.1.2.57","article-title":"Pyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas","volume":"1","author":"Jha","year":"2013","journal-title":"Brain Tumor Res Treat"},{"issue":"5","key":"bib29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.cell.2015.11.011","article-title":"SnapShot: hypoxia-inducible factors","volume":"163","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/EB.S94449","article-title":"Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy","volume":"8","author":"Wang","year":"2016","journal-title":"Eye Brain"},{"key":"bib23","first-page":"585","article-title":"Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity","volume-title":"Am J Ophthalmol","author":"Lambert","year":"2000"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:00Z","timestamp":1791927120000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":31,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.15.23","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}